Inhibitors of Cell Wall Synthesis Flashcards
Peptidoglycan is composed of:
A backbone of two alternating sugars, NAG and NAM,
A chain of four amino acids that are linked to NAM
A peptide bridge that cross links the tetrapeptide chains
Peptidoglycan Synthesis and Abx that prevent the steps
- Transglycosylation: Joining NAM-NAG (PCNs)
- Transpeptidation: Cross links pentapeptides (PCNs)
- NAG reduction to NAM (fosfomycin)
- Transport across the inner membrane (Bacitracin)
- Amino acid mimicry: Pentapeptide chain (Vancomycin)
Target of Beta-lactams
PBPs: involved in Transpeptidation/Transglycosylation
Should not be used with ICWS
Inhibitor of protein synthesis, b/c this stops cell growth which is necessary for ICWS to work
Beta-lactam Drugs
PCNs
Cephalosporins
Monobactams
Carbapenems
ICWS that are NOT beta-lactams
Vancomycin
Fosfomycin
Bacitracin
Natural PCNs
Pen G (IV/IM) Pen V (oral) Benzathine Pen (IM) Procaine Pen G (IM)
Penicillinase Resistant PCNs
Nafcillin (IM/IV)
Dicloxacillin (Oral)
Oxacillin (Oral)
*Methacillin (TESTING ONLY!)
Extended Spectrum PCNs
Ampicillin (Oral)
Amoxicillin (Oral)
Antipseudomonal PCNs
Piperacillin
Ticarcillin
Penicillinase MOA
Hydrolyzes beta-lactam ring of PCNs, so it can’t bind PBPs
Natural PCN spectrum
Mostly G+, some G-
Pen G is the Gold standard for G+ infections
Natural PCN Resistance
Penicillinase producing bacteria (S. aureus)
No antipseudomonal activity
Natural PCN Metabolism
Active transport in kidney - can be slowed with probenecid
PCNase resistant PCN Spectrum
Less G+ than natural, but more G-
PCNase resistant PCN Use
MSSA (DOC) - resistance to penicillinase
PCNase resistant PCN Metabolism
Hepatic metabolism
Renal excretion
MSSA mechanism of resistance
Penicillinase production
MRSA mechanism of resistance
Changes PBP which decreases infinity of beta-lactam abx to PBPs.
NO beta-lactam can be used to treat MRSA except CEFTAROLINE (not the DOC)!
MRSA DOC
Vancomycin
Extended Spectrum PCN Spectrum
Less G+, but extended G- coverage (E. coli, Salmonella, Shigella, H. influenzae, Proteus)
NO Antipseudomonal activity
Extended Spectrum PCN Resistance
Resistance develops frequently!
Susceptible to penicillinase
Extended Spectrum PCN Metabolism
Urinary excretion
Extended Spectrum PCN Use
Lysteria (DOC)
Extended Spectrum PCN Adverse Rxn
Ampicillin rash - Not hypersensitivity rxn
Antipseudomonal PCN Spectrum
Same as extended spectrum PLUS some additional enteric gram negative bacilli (Proteus, Enterobacter, providencia, and Serratia)
Antipseudomonal PCN Use
Pseudomonas aeruginosa (DOC)
Acinetobacter
MUST USE WITH AMINOGLYCOSIDES
Antipseudomonal PCN Resistance
Penicillinase (use penicillinase inhibitor)
Antipseudomonal PCN Metabolism
Renal excretion
Beta-lactamase inhibitors
Clavulanic acid
Sulbactam
Tazobactam
Drugs used with beta-lactamase
Amoxicillin
Ampicillin
Piperacillin
Ticarcillin
Resistance to PCNs
Inactivation of PCN by penicillinase (ie. MSSA)
Decreased permeability (ie. G-)
Alterations in PBPs (ie. MRSA)
Non-growing bacteria or autolytic enzymes not being activated (ie. Listeria, Staphlyocci)
Lack of cell wall (ie. Mycoplasma, Chlamydia)
PCN Toxicity
ALLERGY
Electrolyte imbalances
GI disturbances
Superinfections
PCN Pharmacokinetics
Good tissue penetration
Poor CNS penetration (unless inflammation)
Mostly renal elimination
Filtration and tubular excretion - Probenecid can inhibit renal elimination!
Cephalosporin MOA
Blocking of terminal cross-linking of peptidoglycans
Advantage of Cephalosporins
7-methyl group increases resistance to penicillinase
First Generation Cephalosporin Drugs
Cefazolin (IV/IM)
Cephalexin (Oral)
First Generation Cephalosporin Spectrum
“Narrow Spectrum”
Good G+; Moderate G- (E. coli, Klebsiella, Proteus)
Most G+ cocci are susceptible, MSSA! - Alternative for PCN allergic individuals
First Generation Cephalosporin Use
Cefazolin is DOC for surgical prophylaxis
MSSA! - Alternative for PCN allergic individuals
First Generation Cephalosporin Metabolism
Renal excretion
Second Generation Cephalosporin Drugs
Cefaclor (Oral)
Cefuroxime (IV/IM)
Cefprozil (Oral)
“A U Pretty”
Second Generation Cephalosporin Spectrum
“Intermediate Spectrum”
Lower activity against G+ with increased against G-
NO Antipsuedomonal activity
Second Generation Cephalosporin Metabolism
Renal excretion
Third Generation Cephalosporin Drugs
Ceftriaxone (IV/IM) Cefotaxime Sodium (IV/IM) Ceftazidime (IV/IM) Cefixime (Oral) "Try Taxing Tazmanian Idiots"
Third Generation Cephalosporin Spectrum
“Broad Spectrum”
Less active against G+ cocci
Much more active against Enterobacteriaceae (penicillinasae producing strains)
P. AERUGINOSA activity (Ceftazidime combined w/ aminoglycosides)
Third Generation Cephalosporin Metabolism
Excreted by the kidney
DOC for N. gonorrhoeae
Ceftriaxone
Cephalosporins with CNS penetration
Ceftriaxone and Ceftazidime
Cephalosporin that treats P. aeruginosa
Ceftazidime - MUST combine with aminoglycoside
Ceftriaxone contraindication
Neonates - causes bilirubin displacement
Fourth Generation Cephalosporin Drugs
Cefepime (IV)
Fourth Generation Cephalosporin Spectrum
Comparable to 3rd generation… But better!
Better G+ coverage
Antispeudomonal
More resistant to beta-lactamases
Fourth Generation Cephalosporin Use
Empirical therapy - When you have no clue what bacteria is causing the infection, and it is life threatening!
Fourth Generation Cephalosporin Metabolism
Renal excretion
Fifth Generation Cephalosporin Drugs
Ceftaroline fosamil (IV)
Fifth Generation Cephalosporin Spectrum
G+ and G- activity
NO antipseudomonal activity
Fifth Generation Cephalosporin Use
MRSA/VRSA (when vancomycin doesn’t work)
Only beta-lactam active against MRSA! - Can bind PBP2A
Approved for CAP
Antipseudomonal Beta-lactams
Antipseudomonal PCNs
3rd generation cephalosporins
4th generation cephalosporins
M. catarrhalis DOC
2nd or 3rd generation cephalosporin
N. gonorrhoeae DOC
Ceftriaxone or Cefixime
E. coli, Klebsiella, Proteus DOC
1st or 2nd generation cephalosporin
Salmonella DOC
3rd generation cephalosporin
PCN-resistant S. pneumo DOC
Ceftriaxone
Borrelia burgdorferi late disease DOC
Ceftriaxone
Cephalosporin Toxicity
Fairly safe... Superinfection DISULFIRAM-LIKE RXN Allergy (10% cross sensitivity w/ PCN) GI upset Dose DEPENDENT renal tubular necrosis (Synergistic nephrotoxicity with Aminoglycosides)
Monobactam Drugs
Aztreonam (parenteral)
Aztreonam Spectrum
ONLY Aerobic G- rods!
ie. Pseudomonas, Serratia, Klebsiella, Proteus
NO ACTIVITY against G+ or anaerobes
Aztreonam Adverse Rxns
Few side effects…
Phlebitis, rash, abnormal liver function
Aztreonam Use
Good for PCN allergic (no cross sensitivity w/ other beta-lactams)
Carbapenem Drugs
Imipenem (IV); Cilastin
Meropenem (IV)
Ertapenem (IV/IM)
“I, ME”
What is cilastin?
A dihydropeptidase inhibitor
Why is imipenem given with cilastin?
Imipenem is rapidly inactivated by renal tubule dihydropeptidases. Cilastin blocks these.
***Meropenem is NOT inactivated by dihydropeptidases!
Imipenem and Meropenem Spectrum
BROAD spectrum including anaerobes, G+ and G-
Great for empirical therapy!
Stable against beta-lactamases
Imipenem and Meropenem Use
Mixed infections
Empirical therapy
Imipenem Contraindications
It can cause seizures in HIGH levels, so should be avoided in…
Renal failure
Brain lesions
Head trauma
Hx of CNS disorders
***Meropenem is less likely to cause seizures!
Imipenem is DOC for…?
Beta-lactamse producing Enterobacter infections
Ertapenem Spectrum
Wide variety of G+, G-, and anaerobic microorganisms, particularly Enterobacteriaceae
Highly stable against beta-lactamases
Less active against Pseudomonas, should NOT be used!
Ertapenem Metabolism
Renal elimination
Vancomycin MOA
Prevents transpeptidation of the peptidoglycan chain by binding to the terminal D-ala-D-ala.
Bactericidal
Vancomycin Resistance
Mutation of the terminal D-ala site
Vancomycin Use
MRSA (DOC) - IV C. Diff (DOC) - orally Staphylococcus superinfection - orally G+ infections in PCN-allergic patients Should be used as a LAST RESORT to prevent resistance!
Vancomycin Spectrum
Only G+
Vancomycin Adverse Reactions
Ototoxicity
Nephrotoxicity
“Red man” Syndrome
Thrombophlebitis on IV injection
Fosfomycin MOA
Inhibits cell wall synthesis at one of the first steps of peptidoglycan synthesis:
Prevents NAG to NAM reduction in cytoplasm
Fosfomycin Spectrum
G+ and G- (broad?)
Fosfomycin Administration
Oral
Fosfomycin Use
Uncomplicated UTI (not the DOC)
Fosfomycin is synergistic with what?
Beta-lactam, aminoglycoside, or fluoroquinolone!
Fosfomycin Metabolism
Excreted by the kidney
Bacitracin MOA
Interferes with final dephosphorylation step in the phospholipid carrier cycle:
Can’t transfer NAG-NAM across the inner membrane
Bacitracin Administration
Typically topical (used in neosporin), rarely parenteral (risk of nephrotoxicity)
Bacitracin Spectrum
G+
Bacitracin Use
Most commonly used topically to prevent superficial skin and eye infections following minor injuries